Study shows suppressing herpes virus may reduce infectiousness of HIV

November 16, 2007

A recent study of men co-infected with herpes simplex virus type 2 (HSV-2) and HIV revealed that drugs used to suppress HSV decrease the levels of HIV in the blood and rectal secretions, which may make patients less likely to transmit the virus. This study is published in the November 15 issue of the Journal of Infectious Diseases, now available online.

Most HIV-infected persons are also infected with HSV-2, which is the major cause of genital herpes. Prior studies demonstrated that the risk of passing HIV to a sexual partner is greater when the HIV-infected person has genital ulcers caused by HSV. Previous studies among HIV/HSV-2 co-infected persons and test-tube research have also demonstrated that HIV levels are increased during genital HSV reactivation.

In a pilot study of the effect of HSV-2 suppression on levels of HIV infectiousness, Connie Celum, MD, MPH, Richard Zuckerman, MD, MPH, and a team of researchers at the University of Washington and the research organization Impacta, in Lima, Peru performed a randomized, placebo-controlled cross-over study of daily HSV suppressive treatment in a small group of HIV/HSV-2 co-infected men who have sex with men.

Twenty men aged 22 to 41 enrolled in this trial, which took place in Peru. The men studied had no prior antiretroviral therapy and were not currently receiving antiretroviral therapy for HIV infection. Subjects were randomly assigned to the anti-HSV drug, valacyclovir 500 mg, twice daily or matching placebo for initial treatment. After eight weeks, subjects had a "washout period" in which they received twice daily placebo. Subjects then crossed over to the alternative treatment (placebo or valacyclovir) for eight weeks. Participants visited the clinic three times a week during each treatment arm. At each visit, rectal secretions were collected and weekly blood samples were obtained to determine levels of HIV.

Dr. Celum and her team of researchers found significantly reduced levels of HIV in blood by about 50 percent and rectal secretions by about 30 percent during the 8 weeks when the HIV/HSV-2 co-infected men received valacyclovir to suppress reactivation of HSV. This reduction in HIV levels could have a significant impact on transmission of HIV. Since the only intervention was daily valacyclovir to suppress HSV, this study adds weight to the other evidence that HSV-2 reactivation increases HIV replication. According to the researchers, additional "ongoing randomized trials will answer whether HSV suppression can reduce HIV transmission and address the potential for HSV suppression to delay anti-HIV therapy (antiretroviral) initiation."

Infectious Diseases Society of America

---

---

	Erythema multiforme due to herpes simplex virus: Recurring target lesions are the clue to diagnosis (Postgraduate Medicine) by JTE Multimedia A 75-year-old man presented with a 5-day history of open sores in his mouth and on his lips, tongue, scrotum, and penis. In addition, he had an erythematous, edematous, slightly tender patch on his right palm measuring 2 cm in diameter. Biopsy of a crusted lesion on the scrotum revealed an erosion with underlying mixed inflammation including lymphocytes, neutrophils, and scattered eosinophils. A short course of prednisone and acyclovir was prescribed, and over the next 2 weeks, the lesions cleared. Original Publication Date: October 1999
	The Role of Topical 5% Acyclovir and 1% Hydrocortisone Cream (XereseTM) in the Treatment of Recurrent Herpes Simplex Labialis (Postgraduate Medicine) by JTE Multimedia Recurrent herpes simplex labialis (HSL), also known as orofacial herpes or cold sores, is a common clinical presentation of herpes simplex virus (HSV) infection. It may manifest as painful, distressing, and cosmetically displeasing vesicles on the lips, nose, and nasal septum. Although oral or topical treatment with antiviral agents can reduce the replication of HSV-1, the primary benefits of antiviral therapies for recurrent HSL have been limited to modest reductions in healing time; they do not mitigate the accompanying immune-mediated response of the host to the virus. The addition of a topical corticosteroid to an antiviral cream has been hypothesized to improve the clinical outcome of HSL by decreasing the HSV-related immune-mediated inflammatory skin reaction. A recently developed...
	Managing Herpes: Living & Loving with HSV by American Social Health Association An estimated one million Americans are infected each year with genital herpes. Though most are initially unaware of the infection, those diagnosed may face difficult questions about how they acquired herpes and how to manage it. This book provides a balanced perspective on medical and emotional issues surrounding herpes, including treatment options, transmission, pregnancy, telling your partner, and the impact on sexuality.
	Herpes Simplex Virus Epithelial Keratitis: In Vivo Morphology in the Human Cornea by Helena M. Tabery (Author) This book on Herpes Simplex Virus Epithelial Keratitis shows a kind of ‘living histology’, revealing both morphological and dynamic features of the disease, and explaining mechanisms behind them. It offers great insights helpful for the differential diagnostics and the recognition of less known variants as well as of complications. It is also highly useful for the follow–up of treatment results and the differentiation between an active infection and sequelae. Thus, this book will be an invaluable aid for ophthalmologists and researchers working with ocular surface diseases.
	Herpes Simplex Viruses (Infectious Disease and Therapy) by Marie Studahl (Editor), Paola Cinque (Editor), Tomas Bergstrom (Editor) This reference studies the epidemiology, identification, pathogenesis, and clinical features of diseases associated with herpes simplex viruses including herpes labialis, ocular herpes, herpes genitalis, cutaneous herpes, meningitis, encephalitis, and neonatal herpes-evaluating the latest treatment regimens, mechanisms of immune response and evasion, and research related to vaccines for the prevention and reduction of HSV outbreaks.
	HERPES SIMPLEX VIRUS INFECTIONS: New treatment approaches make early diagnosis even more important (Postgraduate Medicine) by JTE Multimedia Herpes simplex virus infections, ranging from cold sores to severe genital lesions, affect more than 40 million people in the United States. Both the initial episode and recurrent disease can cause devastating problems. However, appropriate treatment can decrease medical and psychosocial consequences in many patients. This article explains the characteristics of herpes simplex infections and outlines treatment options that hold promise for a greatly improved quality of life for many patients. Nadelman CM, Newcomer VD. Herpes simplex virus infections: new treatment approaches make early diagnosis even more important.
	Immunobiology Of Herpes Simplex Virus Infection by Barry T. Rouse (Editor)
	Herpes Outbreaks: A Step By Step Guide To Herpes Treatment Stopping Outbreaks In Less Than 24 Hours by Binders Publishing LLC © Binders Publishing LLC Herpes is a sexually transmitted disease that you have for a lifetime since it can never be cured. That said however, having herpes does not mean a death sentence for those persons who are suffering from it. This is so for the reasons that there are many treatment options for the symptoms that accompany this disease and if you maintain great health, have a properly functioning immune system and limit your intake of alcohol and increase you consumption of anti-herpes foods, then you can greatly diminish the number of herpes outbreaks that you do have and you may even be able to avoid having any of the symptoms that are associated with the herpes virus. The other great news for those individuals who have this disease is that some of...
	Dendritic Cells and Virus Infection (Current Topics in Microbiology and Immunology) by Alexander Steinkasserer (Editor) Dendritic cells are vital to induce potent anti-viral immune responses. It will become clear to the reader that dendritic cells often play a dual role during viral infections. On the one hand they are able to mount potent antiviral immune responses, and on the other hand several viruses, including HIV-1, use DC as a vector to be transferred from the periphery to the lymph nodes where they infect their prime target.
	Chemotherapy of Herpes Simplex Virus Infections by J.S. Oxford (Editor), etc. (Editor)